Cargando…
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial
BACKGROUND: Depression is usually managed in primary care, but most antidepressant trials are of patients from secondary care mental health services, with eligibility criteria based on diagnosis and severity of depressive symptoms. Antidepressants are now used in a much wider group of people than in...
Autores principales: | Lewis, Gemma, Duffy, Larisa, Ades, Anthony, Amos, Rebekah, Araya, Ricardo, Brabyn, Sally, Button, Katherine S, Churchill, Rachel, Derrick, Catherine, Dowrick, Christopher, Gilbody, Simon, Fawsitt, Christopher, Hollingworth, William, Jones, Vivien, Kendrick, Tony, Kessler, David, Kounali, Daphne, Khan, Naila, Lanham, Paul, Pervin, Jodi, Peters, Tim J, Riozzie, Derek, Salaminios, George, Thomas, Laura, Welton, Nicky J, Wiles, Nicola, Woodhouse, Rebecca, Lewis, Glyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029306/ https://www.ncbi.nlm.nih.gov/pubmed/31543474 http://dx.doi.org/10.1016/S2215-0366(19)30366-9 |
Ejemplares similares
-
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial
por: Salaminios, George, et al.
Publicado: (2017) -
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
por: Hollingworth, William, et al.
Publicado: (2019) -
How much change is enough? Evidence from a longitudinal study on depression in UK primary care
por: Kounali, Daphne, et al.
Publicado: (2022) -
The effect of sertraline on emotional processing: secondary analyses of the PANDA randomised controlled trial
por: Ahmed, Norin, et al.
Publicado: (2022) -
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials
por: Bauer-Staeb, Clarissa, et al.
Publicado: (2021)